HopeStage
Back to all studies
CompletedNCT00749203

Ketamine or midazolam for rapid PTSD symptom relief

About this title

Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)

Read the official source — NCT00749203
Medication studyAges 21–55United States
The study in practice

Understand this study

Who was this study for?

This study was for people with PTSD. Listed age limits: 21 years to 55 years. Other eligibility criteria applied.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2009
Recruitment status
Completed
Enrollment listed in the registry
41
Sponsor
Dennis Charney
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT00749203
Official title
Show the full official title

Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Dennis Charney.

Did this study involve medication?

Yes. The study involved medication, including Midazolam and ketamine.

Who was this study for?

This study was for people with PTSD. Listed age limits: 21 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies